XML 33 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 14,802 $ 23,443
Short-term investments 1,997 12,917
Prepaid expenses and other current assets 2,618 1,681
Deferred financing costs, current 1,776 0
Total current assets 21,193 38,041
Property and equipment, net 150 245
Right-of-use assets 100 483
Deferred financing costs, non-current 1,036 0
Other assets 376 327
Total assets 22,855 39,096
Current liabilities:    
Accounts payable 5,343 4,487
Accrued liabilities 5,359 8,488
Deferred revenue 5,659 3,610
Lease liabilities, current portion 106 369
Total current liabilities 16,467 16,954
Derivative warrant liabilities 11 0
Lease liabilities, less current portion 0 141
Total liabilities 16,478 17,095
Commitment and contingencies (Note 9)
Stockholders’ equity:    
Common stock, $0.0001 par value; 1,000,000,000 shares authorized as of March 31, 2023 (unaudited) and December 31, 2022; 24,652,546 and 22,646,015 shares issued and outstanding as of March 31, 2023 (unaudited) and December 31, 2022, respectively [1] 2 2
Additional paid-in capital 183,168 166,727
Accumulated deficit (176,793) (144,724)
Accumulated other comprehensive loss 0 (4)
Total stockholders’ equity 6,377 22,001
Total liabilities and stockholders’ equity $ 22,855 $ 39,096
[1] The balance sheet as of December 31, 2021 presented above reflects the retrospective application of recapitalization as if the Business Combination had occurred on January 1, 2021. See Note 1, 3, and 7.